Linc AB (STO:LINC)

Sweden flag Sweden · Delayed Price · Currency is SEK
65.80
-0.20 (-0.30%)
Mar 4, 2026, 9:50 AM CET
-8.61%
Market Cap 3.81B
Revenue (ttm) -414.00M
Net Income (ttm) -399.65M
Shares Out 57.91M
EPS (ttm) -6.90
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,950
Average Volume 62,680
Open 65.80
Previous Close 65.80
Day's Range 65.60 - 66.20
52-Week Range 58.90 - 83.60
Beta 0.76
RSI 50.37
Earnings Date Apr 21, 2026

About Linc AB

Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million ($2.99 million) and SEK 250 million ($29.9... [Read more]

Sector Financials
Founded 1991
Employees 2
Stock Exchange Nasdaq Stockholm
Ticker Symbol LINC
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.